Showing results (21-30 of 159) with videos related to

Sort By:
Pageof 16
British Journal of Haematology|February 6, 2016
Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 1b study from GELTAMO groupAlejandro Martín, Alba M Redondo, Iván Dlouhy, et al.
Therapeutic Advances in Hematology|April 5, 2013
Long-Term Results of Fludarabine/Melphalan as a Reduced-Intensity Conditioning Regimen in Mantle Cell Lymphoma: The GELTAMO ExperienceJorge Gayoso Cruz, Rodrigo Martino, Pascual Balsalobre, et al.
Annals of Hematology|May 30, 2013
Clinical practice guidelines for diagnosis, treatment, and follow-up of patients with mantle cell lymphoma. Recommendations from the GEL/TAMO Spanish Cooperative GroupDolores Caballero, Elías Campo, Armando López-Guillermo, et al.
Blood|March 22, 2003
Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantationJose A Perez-Simon, Maria Diez-Campelo, Rodrigo Martino, et al.
Haematologica|August 6, 2002
Cyclophosphamide, pegylated liposomal doxorubicin (Caelyx), vincristine and prednisone (CCOP) in elderly patients with diffuse large B-cell lymphoma: results from a prospective phase II studyRodrigo Martino, Granada Perea, María Dolores Caballero, et al.
Annals of Hematology|June 8, 2010
Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemiaFrancisco Javier Peñalver, Alberto Alvarez-Larrán, Jose Luis Díez-Martin, et al.
Hematology Reports|January 9, 2015
Late differentiation syndrome in acute promyelocytic leukemia: a challenging diagnosisRenata Cabral, Juan Carlos Caballero, Sara Alonso, et al.
Haematologica|October 16, 2012
The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolateJose Antonio Perez-Simón, Rodrigo Martino, Rocío Parody, et al.
Haematologica|October 4, 2017
Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphomaAnas Younes, Gilles Salles, Giovanni Martinelli, et al.
Investigative Ophthalmology & Visual Science|July 23, 2015
Gene Expression-Based Predictive Models of Graft Versus Host Disease-Associated Dry EyeLidia Cocho, Itziar Fernández, Margarita Calonge, et al.
Pageof 16